{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:26:40Z","timestamp":1790177200755,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.neuro.2004.07.009","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T18:27:57Z","timestamp":1095186477000},"page":"27-38","source":"Crossref","is-referenced-by-count":15,"title":["Lysophosphatidylcholine Decreases Locomotor Activities and Dopamine Turnover Rate in Rats"],"prefix":"10.1016","volume":"26","author":[{"given":"Eun-Sook Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam F.A.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clivel G.","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2004.07.009_bib1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s007020070047","article-title":"N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test","volume":"107","author":"Aoyama","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuro.2004.07.009_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0304-3940(00)01723-7","article-title":"Nicotinamide-N-methyltransferase is higher in the lumbar cerebrospinal fluid of patients with Parkinson's disease","volume":"298","author":"Aoyama","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2004.07.009_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0005-2760(97)00045-3","article-title":"The high-affinity quinacrine binding site is located at a non-annular lipid domain of the nicotinic acetylcholine receptor","volume":"1347","author":"Arias","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuro.2004.07.009_bib4","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuro.2004.07.009_bib5","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/j.1471-4159.1983.tb00881.x","article-title":"Stimulation of phospholipase A2 and secretion of catacholamines from brain synaptosomes by potassium and A 23187","volume":"41","author":"Bradford","year":"1983","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuro.2004.07.009_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02816115","article-title":"Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain","volume":"9","author":"Charlton","year":"1994","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuro.2004.07.009_bib7","first-page":"560","article-title":"Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion","volume":"241","author":"Chiariello","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuro.2004.07.009_bib8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0002-8703(90)90195-4","article-title":"Reduction in infarct size by the phospholipase inhibitor quinacrine in dogs with coronary artery occlusion","volume":"120","author":"Chiariello","year":"1990","journal-title":"Am. Heart J."},{"key":"10.1016\/j.neuro.2004.07.009_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(84)90221-8","article-title":"Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat","volume":"100","author":"Chiueh","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuro.2004.07.009_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0006-8993(92)90576-U","article-title":"Indole-N-methylated beta-carbolinium ions as potential brain-bioactivated neurotoxins","volume":"570","author":"Collins","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neuro.2004.07.009_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0163-1047(93)90950-M","article-title":"S-Adenosyl-l-methionine decreases motor activity in the rat: similarity to Parkinson's disease-like symptoms","volume":"59","author":"Crowell","year":"1993","journal-title":"Behav. Neural Biol."},{"key":"10.1016\/j.neuro.2004.07.009_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(93)90274-O","article-title":"Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat","volume":"161","author":"Desole","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2004.07.009_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0015-0282(16)46703-8","article-title":"Pharmacokinetic studies on quinacrine following intrauterine administration to Cynomolgus monkeys","volume":"38","author":"Dubin","year":"1982","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.neuro.2004.07.009_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0006-8993(96)01450-3","article-title":"The phospholipase A2 inhibitor, quinacrine, reduces infarct size in rats after transient middle cerebral artery occlusion","volume":"752","author":"Estevez","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuro.2004.07.009_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1027351120616","article-title":"Characterization of brain \u03b2-carboline-2-N-methyltransferase, an enzyme that may play a role in idiopathic Parkinson's disease","volume":"22","author":"Gearhart","year":"1997","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuro.2004.07.009_bib16","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1073\/pnas.75.4.1718","article-title":"Identification and properties of two methyltransferases in conversion of phosphatidylethanolamine to phosphatidylcholine","volume":"75","author":"Hirata","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuro.2004.07.009_bib17","first-page":"925","article-title":"Dopamine (3-hydroxytyramine) and brain function","volume":"18","author":"Hornykiewicz","year":"1966","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuro.2004.07.009_bib18","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1016\/0006-2952(86)90390-4","article-title":"Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes","volume":"35","author":"Hurst","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuro.2004.07.009_bib19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0169-328X(96)00292-6","article-title":"Long-lasting enhancement of cholinergic receptor currents by lysophospholipids","volume":"45","author":"Ikeuchi","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuro.2004.07.009_bib20","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1021\/bi960123p","article-title":"Quinacrine noncompetitive inhibitor binding site localized on the Torpedo acetylcholine receptor in the open state","volume":"35","author":"Johnson","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuro.2004.07.009_bib21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1126\/science.1061781","article-title":"Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A","volume":"293","author":"Kabarowski","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuro.2004.07.009_bib22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neuro.2004.07.009_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0006-8993(79)90311-1","article-title":"Blockade by benzodiazepines of the selective high increase in dopamine turnover induced by stress in mesocortical dopaminergic neurons of the rat","volume":"168","author":"Lavielle","year":"1979","journal-title":"Brain Res."},{"key":"10.1016\/j.neuro.2004.07.009_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0091-3057(01)00588-3","article-title":"One-methyl-4-phenyl-pyridinium (MPP+) increases S-adenosyl-l-methionine dependent phospholipid methylation","volume":"70","author":"Lee","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuro.2004.07.009_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.neures.2003.11.010","article-title":"The inhibitory role of methylation on the binding characteristics of dopamine receptors and transporter","volume":"48","author":"Lee","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuro.2004.07.009_bib26","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1023\/B:NERE.0000026394.92363.ee","article-title":"Inhibitory effects of lysophosphatidylcholine on the dopaminergic system","volume":"29","author":"Lee","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuro.2004.07.009_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000113187","article-title":"Catecholamines and indoleamines in the central nervous system of a urodele amphibian: a microdissection study with emphasis on the distribution of epinephrine","volume":"48","author":"Lowry","year":"1996","journal-title":"Brain Behav. Evol."},{"key":"10.1016\/j.neuro.2004.07.009_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s004240050142","article-title":"Exogenous lysophosphatidylcholine increases non-selective cation current in guinea-pig ventricular myocytes","volume":"432","author":"Magishi","year":"1996","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.neuro.2004.07.009_bib29","first-page":"288","article-title":"Lysophosphatidylcholine-induced gastric injury and ulceration in the guinea pig","volume":"115","author":"Maksem","year":"1984","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuro.2004.07.009_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0005-2736(95)00171-4","article-title":"Lysophosphatidylcholine inhibits vesicles fusion induced by the NH2-terminal extremity of SIV\/HIV fusogenic proteins","volume":"1240","author":"Martin","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuro.2004.07.009_bib31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1471-4159.1998.70020727.x","article-title":"Endogenously occurring \u03b2-carboline induces Parkinsonism in non-primate animals: a possible causative pro-toxin in idiopathic Parkinson's disease","volume":"70","author":"Matsubara","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuro.2004.07.009_bib32","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/bj3180701","article-title":"Release of secretory phospholipase A2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion","volume":"318","author":"Matsuzawa","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuro.2004.07.009_bib33","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0006-2952(96)00091-3","article-title":"Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration","volume":"51","author":"McNaught","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuro.2004.07.009_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0304-3940(94)11138-9","article-title":"Effects of allopurinol on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurochemical changes in the striatum and in the brainstem of the rat","volume":"183","author":"Miele","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2004.07.009_bib35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.6278597","article-title":"Interaction of brain synaptic vesicles induced by endogenous Ca2+-dependent phospholipase A2","volume":"216","author":"Moskowitz","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neuro.2004.07.009_bib36","first-page":"197","article-title":"Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin","volume":"Suppl. 41","author":"Naoi","year":"1994","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuro.2004.07.009_bib37","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1042\/bj3180981","article-title":"Ca2+-independent fusion of synaptic vesicles with phospholipase A2-treated presynaptic membranes in vitro","volume":"318","author":"Nishio","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuro.2004.07.009_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1096\/fasebj.9.7.7737456","article-title":"Protein kinase C and lipid signaling for sustained cellular responses","volume":"9","author":"Nishizuka","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/j.neuro.2004.07.009_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1471-4159.1984.tb00921.x","article-title":"Effect of phospholipase digestion and lysophosphatidylcholine on dopamine receptor binding","volume":"43","author":"Oliveira","year":"1984","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuro.2004.07.009_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(95)11672-J","article-title":"Arachidonic acid and lysophosphatidylcholine modulate excitatory transmitter amino acid release from the rat cerebral cortex","volume":"193","author":"O\u2019Regan","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2004.07.009_bib41","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/227810a0","article-title":"Lysolecithin and cell fusion","volume":"227","author":"Poole","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2004.07.009_bib42","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1073\/pnas.85.8.2805","article-title":"Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis","volume":"85","author":"Quinn","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuro.2004.07.009_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","article-title":"Reduction of cortical dopamine, noradrenalin, serotonin and their metabolites in Parkinson's disease","volume":"275","author":"Scatton","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.neuro.2004.07.009_bib44","series-title":"Handbook of clinical neurology. Disease of the basal ganglia","first-page":"173","article-title":"Parkinson's disease","author":"Selby","year":"1975"},{"key":"10.1016\/j.neuro.2004.07.009_bib45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0047-6374(88)90044-9","article-title":"The carboxylmethylation of cerebral membrane-bound proteins increases with age","volume":"43","author":"Sellinger","year":"1988","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.neuro.2004.07.009_bib46","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1073\/pnas.73.5.1586","article-title":"Regulation of guanylate and adenylate cyclase activities by lysolecithin","volume":"73","author":"Shier","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuro.2004.07.009_bib47","doi-asserted-by":"crossref","unstructured":"Slomiany BL, Jerzy-Glass GB, Kojima K, Banas-Gruszka Z, Slomiany A. Effect of lysolecithin on the constituents of gastric mucus. In: Chantler N, Elder JB, Elstein M., editors. International symposium on mucus in health and disease; 1981. p. 163\u201374.","DOI":"10.1007\/978-1-4615-9254-9_24"},{"key":"10.1016\/j.neuro.2004.07.009_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0361-9230(00)00427-5","article-title":"Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents","volume":"54","author":"Tariq","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuro.2004.07.009_bib49","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1471-4159.1992.tb08353.x","article-title":"Unsaturated fatty acids esterified in 2-acyl-l-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the un-esterified form","volume":"59","author":"Thies","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuro.2004.07.009_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-3940(93)90111-W","article-title":"Concentrations of serotonin and its related substances in the cerebrospinal fluid of Parkinsonian patients and their relations to the severity of symptoms","volume":"150","author":"Tohgi","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2004.07.009_bib51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0006-8993(81)90358-9","article-title":"Mepacrine treatment prevents immobilization-induced desensitization of beta-adrenergic receptors in rat hypothalamus and brain stem","volume":"205","author":"Torda","year":"1981","journal-title":"Brain Res."},{"key":"10.1016\/j.neuro.2004.07.009_bib52","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.1016\/S0021-9258(18)42433-7","article-title":"Quinacrine binds to the lipid-protein interface of the Torpedo acetylcholine receptor: a fluorescence study","volume":"267","author":"Valenzuela","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuro.2004.07.009_bib53","doi-asserted-by":"crossref","first-page":"25764","DOI":"10.1016\/S0021-9258(19)74455-X","article-title":"Lysophosphatidylcholine reversibly arrests exocytosis and viral fusion at a stage between triggering and membrane merger","volume":"268","author":"Vogel","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuro.2004.07.009_bib54","first-page":"194","article-title":"N-methylation of pyridines and Parkinson's disease","volume":"60","author":"Williams","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neuro.2004.07.009_bib55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1388-1981(02)00140-3","article-title":"Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction","volume":"1582","author":"Xu","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuro.2004.07.009_bib56","doi-asserted-by":"crossref","first-page":"27090","DOI":"10.1074\/jbc.271.43.27090","article-title":"The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase","volume":"271","author":"Yuan","year":"1996","journal-title":"J. Biol. Chem."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X04001068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X04001068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T17:58:40Z","timestamp":1624643920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X04001068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0161813X04001068"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2004.07.009","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}